Albutein 5%
Sponsors
Instituto Grifols, S.A., Grifols Therapeutics LLC
Conditions
Alzheimer's DiseaseAmyotrophic Lateral Sclerosis
Phase 2
Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid
CompletedNCT00742417
Start: 2007-07-31End: 2011-03-31Updated: 2016-06-14
Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral Sclerosis
CompletedNCT02872142
Start: 2016-08-29End: 2019-08-15Updated: 2021-05-05